TY - JOUR T1 - Epidemiological investigation of the first 135 COVID-19 cases in Brunei: Implications for surveillance, control, and travel restrictions JF - medRxiv DO - 10.1101/2020.06.29.20142463 SP - 2020.06.29.20142463 AU - Justin Wong AU - Liling Chaw AU - Wee Chian Koh AU - Mohammad Fathi Alikhan AU - Sirajul Adli Jamaludin AU - POH Wan Wen Patricia AU - Lin Naing Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/30/2020.06.29.20142463.abstract N2 - Background Studies on the early introduction of SARS-CoV-2 in a naïve population have important epidemic control implications. We report findings from the epidemiological investigation of the initial 135 COVID-19 cases in Brunei and describe the impact of control measures and travel restrictions.Methods Epidemiological and clinical information were obtained for all confirmed COVID-19 cases in Brunei, whose symptom onset was from March 9 to April 5, 2020 (covering the initial 5 weeks of the epidemic). Transmission-related measures such as reproduction number (R), incubation period, serial interval were estimated. Time-varying R was calculated to assess the effectiveness of control measures.Results A total of 135 cases were detected, of which 53 (39.3%) were imported. The median age was 36 years (range = 0.5 to 72). 41 (30.4%) and 13 (9.6%) were presymptomatic and asymptomatic cases respectively. The median incubation period was 5 days (IQR = 5, range = 1 to 11), and the mean serial interval was 5.39 days (sd = 4.47; 95% CI: 4.25, 6.53). R0 was between 3.88 and 5.96, and the doubling time was 1.3 days. By the 13th day of the epidemic, the Rt was under one (Rt = 0.91; 95% credible interval: 0.62, 1.32) and the epidemic was under control.Conclusion Epidemic control was achieved through a combination of public health measures, with emphasis on a test-isolate-trace approach supplemented by travel restrictions and moderate physical distancing measures but no actual lockdown. To maintain suppression, regular and ongoing testing of high-risk groups can supplement the existing surveillance program.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study does not receive any form of financial support.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University Research Ethics Committee, Universiti Brunei DarussalamAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the corresponding author, upon reasonable request. ER -